News & Publications
News

Nov 4, 2026
Rebecca Abergel to present at Sixth REAC/TS International Symposium
Nov 1, 2026
HOPO Therapeutics enters Participant Basic Agreement with U.S. Army Contracting Command

Jun 3, 2026
Julian Rees presents HOPO-101 at Second Annual Research Conference on Global Lead Exposure

May 29, 2026
HOPO Therapeutics joins the Medical Countermeasures Coalition

May 21, 2026
Josh Godshaw presents at CBRNE Research & Innovation conference in France

May 19, 2026
Morri Markowitz, MD joins HOPO Therapeutics as clinical advisor
Publications
Proceedings of the National Academy of Sciences • Apr 2021
Genome-wide toxicogenomic study of the lanthanides sheds light on the selective toxicity mechanisms associated with critical materials
Roger M. Pallares, David Faulkner, Dahlia D. An, Solene Hebert, Alex Loguinov, Michael Proctor, Jonathan A. Villalobos, Kathleen A. Bjornstad, Chris J. Rosen, Christopher Vulpe, Rebecca J. Abergel
Nature • Feb 2021
Structural and spectroscopic characterization of an einsteinium complex
Korey P. Carter, Katherine M. Shield, Kurt F. Smith, Zachary R. Jones, Jennifer N. Wacker, Leticia Arnedo-Sanchez, Tracy M. Mattox, Liane M. Moreau, Karah E. Knope, Stosh A. Kozimor, Corwin H. Booth, Rebecca J. Abergel
Scientific Reports • Mar 2018
Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents
Julian A. Rees, Gauthier J.-P. Deblonde, Dahlia D. An, Camille Ansoborlo, Stacey S. Gauny, Rebecca J. Abergel
New Journal of Chemistry • Feb 2018
Toxic heavy metal – Pb, Cd, Sn – complexation by the octadentate hydroxypyridinonate ligand archetype 3,4,3-LI(1,2-HOPO)
Gauthier J.P. Deblonde, Trevor D. Lohrey, Dahlia D. An, Rebecca J. Abergel